RIPK1 and cancer: Receptor-interacting protein kinase 1 has emerged as a crucial regulator in various human diseases such like cancers, neurodegeneration, autoimmune, and inflammatory diseases (Ofengeim and Yuan, 2013; Liu et al., 2015; Ofengeim et al., 2017; Wang et al., 2018; Tao et al., 2020).